NCT06107374View on ClinicalTrials.gov

Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG

PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

March 31, 2026

Conditions
Advanced Non Small Cell Lung Cancer
Interventions
DRUG

[18F]F-AraG

Two PET scans

Trial Locations (1)

52246

RECRUITING

University of Iowa Hospitals and Clinics, Iowa City

Sponsors
All Listed Sponsors
lead

CellSight Technologies, Inc.

INDUSTRY